Mortality in Dravet syndrome.

Area of Science:

• Neurology
• Epileptology
• Clinical Genetics

Background:

• Dravet Syndrome (DS) is a severe form of epilepsy often linked to SCN1A mutations.
• Sudden Unexpected Death in Epilepsy (SUDEP) is a critical outcome in epilepsy, but syndrome-specific rates are poorly defined.
• Understanding DS-specific mortality is crucial for patient management and risk assessment.

Purpose of the Study:

• To quantify the mortality rate and the rate of SUDEP in a cohort of patients with Dravet Syndrome.
• To establish the first documented syndrome-specific SUDEP rate for Dravet Syndrome.
• To compare the SUDEP rate in DS with that of refractory epilepsy in adults.

Main Methods:

• A cohort study of 100 consecutively recruited, unrelated patients with Dravet Syndrome was conducted.
• Mortality and causes of death, including SUDEP, were systematically recorded.
• Follow-up data for living patients extended to a median of 17 years.

Main Results:

• Seventeen out of 100 patients died, with a median age of death at seven years.
• The leading cause of death was SUDEP (10 cases), followed by status epilepticus, drowning, and asphyxia.
• The Dravet-specific mortality rate was 15.84/1000-person-years, and the SUDEP rate was 9.32/1000-person-years.
• The SUDEP rate in DS is significantly higher than in adults with refractory epilepsy (9.32 vs. 5.1/1000-person-years).

Conclusions:

• Sudden Unexpected Death in Epilepsy (SUDEP) is a major cause of mortality in Dravet Syndrome, predominantly affecting children.
• Dravet Syndrome exhibits the highest documented syndrome-specific SUDEP rate, highlighting the urgent need for targeted preventative strategies.
• This study provides critical data for understanding and potentially mitigating SUDEP risk in Dravet Syndrome patients.